Research Article
In Silico Investigation of Potential Pyruvate Kinase M2 Regulators from Traditional Chinese Medicine against Cancers
Table 2
H-bond occupancy for key residues of PKM2 protein with top TCM compounds overall 10,000 ps of molecular dynamics simulation.
| Ligand | H-bond | Ligand atoms | Amino acid | Distance (nm) | Occupancy (%) | Max. | Min. | Average |
| Saussureamine C | 1 | O23 | A:Lys311:HZ3 | 0.553 | 0.259 | 0.438 | 15.80% | 2 | O24 | A:Lys311:HZ3 | 0.57 | 0.146 | 0.294 | 94.80% | 3 | N27 | A:Lys311:HZ3 | 0.593 | 0.234 | 0.408 | 30.00% | 4 | O28 | B:Lys311:HZ3 | 0.726 | 0.161 | 0.519 | 10.40% | 5 | O28 | B:Lys311:HZ3 | 0.63 | 0.15 | 0.31 | 73.20% | 6 | H50 | B:Lys311:NZ | 0.76 | 0.24 | 0.43 | 46.20% | 7 | H50 | A:Asn350:OD1 | 0.64 | 0.16 | 0.36 | 44.80% | 8 | H52 | B:Asp354:OD1 | 0.54 | 0.27 | 0.31 | 96.20% | 9 | H50 | B:Asp354:OD1 | 0.66 | 0.19 | 0.49 | 20.40% | 10 | H50 | B:Asp354:OD2 | 0.79 | 0.15 | 0.51 | 23.20% |
| Precatorine | 1 | O18 | A:Lys311:HZ3 | 0.39 | 0.14 | 0.29 | 98% | 2 | O19 | B:His29:HE2 | 0.41 | 0.15 | 0.19 | 97% | 3 | O20 | B:Tyr390:HN | 0.58 | 0.17 | 0.24 | 91% | 4 | H29 | B:Leu353:O | 0.52 | 0.16 | 0.37 | 25% |
| NZT* | 1 | O12 | A:Tyr390:HN | 0.32 | 0.16 | 0.19 | 100% | 2 | O13 | A:Tyr390:HN | 0.46 | 0.17 | 0.37 | 15% | 3 | O22 | B:Lys311:HZ3 | 0.78 | 0.15 | 0.42 | 53% | 4 | N28 | B:Gln393:HE22 | 1.03 | 0.23 | 0.56 | 18% | 5 | N30 | B:Gln393:HE22 | 0.99 | 0.19 | 0.49 | 40% | 6 | H41 | A:Leu353:O | 0.30 | 0.16 | 0.20 | 100% |
|
|
H-bond occupancy cutoff: 0.35 nm.
*Control: N-(4-((4-(pyrazin-2-yl)piperazin-1-yl)carbonyl)phenyl)quinoline-8-sulfonamide.
|